<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Liver flukes: Clonorchis, Opisthorchis, and Metorchis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Liver flukes: Clonorchis, Opisthorchis, and Metorchis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Liver flukes: Clonorchis, Opisthorchis, and Metorchis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karin Leder, MBBS, FRACP, PhD, MPH, DTMH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward T Ryan, MD, DTMH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The three major liver flukes (trematodes) that infect humans are <em>Clonorchis sinensis</em>, <em>Opisthorchis </em>species, and <em>Fasciola hepatica </em>[<a href="#rid1">1</a>]. The North American liver fluke, <em>Metorchis conjunctus, </em>is a less common liver fluke. Liver fluke infections are acquired via ingestion of raw, undercooked, salted, dried, pickled, or smoked freshwater fish from endemic areas. </p><p>Issues related to clonorchiasis, opisthorchiasis, and <em>M. conjunctus</em> will be reviewed here. Fascioliasis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5676.html" rel="external">"Liver flukes: Fascioliasis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLONORCHIASIS AND OPISTHORCHIASIS</span><span class="headingEndMark"> — </span><em>Opisthorchis</em> and <em>Clonorchis</em> infections are similar with respect to life cycle, clinical manifestations, diagnosis, treatment, and prevention (as discussed in the following sections).</p><p class="headingAnchor" id="H3"><span class="h2">Epidemiology</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clonorchiasis</strong> – Clonorchiasis is caused by <em>C. sinensis</em> (or <em>Opisthorchis sinensis</em>), also known as the Chinese liver fluke. It is endemic in East Asia (mainly in China, Japan, Korea, Taiwan, and Vietnam) [<a href="#rid2">2</a>], as well as far eastern Russia  (<a class="graphic graphic_figure graphicRef134623" href="/z/d/graphic/134623.html" rel="external">figure 1</a>) [<a href="#rid3">3-5</a>]. <em>Clonorchis</em> is a parasite of fish-eating mammals; dogs and cats are the most common reservoirs [<a href="#rid6">6</a>]. More than 35 million people are infected worldwide, with 600 million at risk [<a href="#rid7">7</a>]. Prevalence rates in endemic areas vary widely; in different provinces of China, for example, the prevalence ranges from &lt;1 to 57 percent [<a href="#rid8">8</a>]. One study in Korea noted a prevalence of 16 percent [<a href="#rid9">9</a>]. </p><p></p><p class="bulletIndent1">Reinfection rates are high in endemic areas. In one study including 436 individuals treated for clonorchiasis, the reinfection rate at 12 months was 40 percent [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Opisthorchiasis</strong> – Opisthorchiasis is generally caused by <em>Opisthorchis felineus</em> or <em>Opisthorchis viverrini</em>. These are liver flukes of cats, dogs, and other fish-eating mammals, which serve as reservoir hosts. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>O. felineus</em> occurs in Southeast Asia and in Central and Eastern Europe, particularly in Siberia and other parts of the former Soviet Union [<a href="#rid11">11,12</a>]. Prevalence rates are 40 to 95 percent in some areas, and it is estimated that more than 16 million people are infected [<a href="#rid13">13</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>O. viverrini</em> is endemic in Thailand, Vietnam, Cambodia, Laos, China, and Myanmar [<a href="#rid14">14</a>]. Prevalence rates of over 24 to 90 percent in villages in Thailand and 40 to 80 percent in Laos have been reported, and it is estimated that worldwide over 23 million people are infected, including 15 million in China [<a href="#rid2">2,5,13,15</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infection outside endemic areas</strong> – Travelers to or immigrants from endemic areas may harbor the infection and import it to nonendemic areas. Surveys in the United States have shown that Southeast Asian immigrants may have liver fluke infection [<a href="#rid16">16</a>]. In addition, frozen, dried, or pickled fish that contain surviving metacercariae can be exported to nonendemic areas; therefore, occasionally infection occurs in individuals who have never traveled to endemic areas [<a href="#rid17">17,18</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Life cycle and pathogenesis</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outside the host</strong> – The life cycle begins with release of embryonated eggs in stool  (<a class="graphic graphic_figure graphicRef53219" href="/z/d/graphic/53219.html" rel="external">figure 2</a>). Eggs are ingested by a snail (first intermediate host), where miracidia are released and go through several developmental stages (sporocysts, rediae, and cercariae). The cercariae are released from the snail into fresh water and subsequently penetrate the flesh of freshwater fish (second intermediate host), where they encyst as metacercariae. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Within the host</strong> – Animals or humans acquire infection via ingestion of raw, undercooked, salted, pickled, or smoked freshwater fish (such as carp or salmon). The metacercariae excyst in the host duodenum and ascend the biliary tract. </p><p></p><p class="bulletIndent1">Maturation to adult flukes takes approximately one month. The adult flukes are hermaphroditic and generally reside in small- and medium-sized biliary ducts; occasionally, they reside in the gallbladder or pancreatic duct. They are dorsoventrally flattened, 10 to 23 mm in length, and the body has an anterior oral sucker and a ventral sucker at midbody. The adults can persist in situ for years; there is no tissue migration. Embryonated eggs are released into the host biliary ducts and subsequently into the stool. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis of biliary injury</strong> – Initial metacercariae migration causes trauma to the bile duct epithelium, leading to ulceration and desquamation. Early infection may be associated with subcapsular bile duct dilatation, adenomatous hyperplasia of the bile duct epithelium (with or without periductal fibrosis), goblet cell metaplasia, and eosinophilic infiltration. Repeated exposures may provoke diffuse biliary involvement, including the large bile ducts and gallbladder. </p><p></p><p class="headingAnchor" id="H5"><span class="h2">Clinical manifestations</span></p><p class="headingAnchor" id="H1458377267"><span class="h3">Risk of symptomatic illness</span><span class="headingEndMark"> — </span>Most acutely infected individuals are asymptomatic. The risk of symptomatic infection increases with the duration and intensity of infection. Symptoms are rare in the setting of ‘light’ infection (20 to 200 adult flukes or up to 1000 eggs per gram of stool) [<a href="#rid19">19</a>]. Among individuals with ‘heavy’ infection (as many as 20,000 adult flukes), symptoms occur in approximately 5 to 10 percent of cases and the risk of severe hepatobiliary manifestations is increased more than three-fold [<a href="#rid20">20,21</a>]. </p><p>Symptomatic infection is most common among older adults in endemic areas (given risk for ongoing exposure and increased worm burden with age); onset of symptoms may be delayed for many years following initial infection. Less commonly, symptomatic infection may develop within a few weeks following consumption of heavily infected undercooked fish. </p><p class="headingAnchor" id="H6"><span class="h3">Acute infection</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manifestations common to all pathogens</strong> – Clinical manifestations of acute infection include right upper quadrant abdominal pain, anorexia, nausea, vomiting, diarrhea, weight loss, flatulence, and fatigue [<a href="#rid22">22</a>]. Additional signs and symptoms may include fever, ascites, hepatomegaly, lymphadenopathy, myalgia, arthralgia, and urticaria [<a href="#rid1">1</a>]. Acute symptoms usually last for two to four weeks.  </p><p></p><p class="bulletIndent1">Eggs generally become detectable in the stool three to four weeks after exposure. High levels of circulating eosinophils (10 to 20 percent) are common. Liver function tests may be elevated, often with a cholestatic pattern with elevated alkaline phosphatase and gamma-glutamyl transferase [<a href="#rid23">23</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manifestations specific to </strong><strong><em>O. felineus</em></strong><strong> </strong>– Unique features of <em>O. felineus</em> infection include fever, chills, hepatosplenomegaly, abdominal tenderness, and high-grade eosinophilia (up to 40 percent) [<a href="#rid24">24</a>]. These symptoms occur early in infection and may be associated with primary exposure to a large dose of metacercariae.</p><p></p><p class="headingAnchor" id="H7"><span class="h3">Chronic infection and complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late manifestations</strong> – Late manifestations of liver fluke infection may include biliary obstruction (as well as strictures and/or dilatation), stone formation, cholangitis, cholecystitis, liver abscess, pancreatitis, hepatitis, and cirrhosis. Signs and symptoms may include fatigue, abdominal discomfort, jaundice, anorexia, weight loss, and dyspepsia [<a href="#rid25">25</a>].  </p><p></p><p class="bulletIndent1">Elevated total bilirubin and alkaline phosphatase levels reflect obstruction; elevated transaminase levels reflect hepatic injury. Peripheral eosinophilia occurs in approximately half of cases and typically is mild (500 to 1000/microL) [<a href="#rid26">26,27</a>]. </p><p></p><p class="bulletIndent1">These manifestations occur as a result of chronic epithelial irritation, leading to hepatic fibrosis. In addition, immunosuppressive mechanisms may facilitate parasite persistence, allowing ongoing biliary inflammation [<a href="#rid28">28</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cholangiocarcinoma</strong> – Patients with clonorchiasis or opisthorchiasis are at risk for cholangiocarcinoma, particularly in the setting of heavy infection [<a href="#rid1">1,29</a>]. Risk factors include diabetes and <em>Helicobacter pylori</em> infection [<a href="#rid30">30-32</a>]. Symptoms of cholangiocarcinoma include jaundice, weight loss, epigastric pain, abdominal mass, and ascites. (see  <a class="medical medical_review" href="/z/d/html/663.html" rel="external">"Epidemiology, risk factors, anatomy, and pathology of cholangiocarcinoma"</a> and  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma"</a>)</p><p></p><p class="bulletIndent1">In one meta-analysis including 181 studies and 56 million people with food-borne trematode infection, the odds ratios for cholangiocarcinoma with clonorchiasis or opisthorchiasis were 6.1 (95% CI 4.3-8.7) and 4.4 (95% CI 1.0-18.5), respectively [<a href="#rid33">33</a>]. </p><p></p><p class="bulletIndent1">The mechanisms of carcinogenesis are uncertain; they may include chronic inflammation and mechanical damage to the bile duct epithelium, nitric oxide formation, genetic alterations, protein dysregulation, activation of drug-metabolizing enzymes, coinfection, changes in the biliary tract microbiome and parasitic production of oncogenic molecules [<a href="#rid34">34-37</a>].</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Diagnosis</span></p><p class="headingAnchor" id="H1537543517"><span class="h3">Clinical approach</span><span class="headingEndMark"> — </span>The diagnosis of clonorchiasis or opisthorchiasis should be suspected in individuals with relevant epidemiologic exposure (consumption of raw or undercooked fish from endemic areas) and typical clinical manifestations (fatigue, abdominal discomfort, jaundice, anorexia, weight loss, dyspepsia), with or without eosinophilia. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Clinical manifestations'</a> above.)</p><p>The diagnosis of clonorchiasis or opisthorchiasis may be established by identifying eggs in stool; eggs generally become detectable in the stool three to four weeks after exposure. In addition, ultrasonography should be pursued to evaluate the biliary tract and assess for findings warranting acute intervention (such as presence of biliary duct stones, cholangitis, cholecystitis, or abscess). </p><p>For patients with an indication for biliary decompression (such as biliary duct stones and/or cholangitis), the diagnosis may be made by identifying eggs or adult worms in bile. Occasionally, eggs are also recovered from other sites such as duodenal aspirates or gastric washings [<a href="#rid1">1</a>]. </p><p>A diagnosis of clonorchiasis or opisthorchiasis should prompt evaluation of family members with stool microscopy and blood count (to evaluate for eosinophilia). For individuals with eosinophilia but negative stool microscopy, ultrasonography to evaluate for findings consistent with fluke infection is warranted; the presence of such findings supports a presumptive diagnosis of fluke infection, warranting treatment. (See <a class="local">'Imaging'</a> below and <a class="local">'Treatment'</a> below.)</p><p>Additional diagnostic tools (serologic, antigen, and molecular tests) have been developed but are not widely available. </p><p class="headingAnchor" id="H1584956018"><span class="h3">Diagnostic tools</span></p><p class="headingAnchor" id="H10"><span class="h4">Microscopy</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Technique</strong> – The preferred microscopy method is the formalin ethyl-acetate concentration technique. Kato-Katz thick smears can also be used. (See  <a class="medical medical_review" href="/z/d/html/14001.html" rel="external">"Approach to stool microscopy", section on 'Specimen collection and preparation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Egg identification</strong> – Eggs are detectable in the stool approximately four weeks following infection. </p><p></p><p class="bulletIndent1">Distinguishing between <em>Clonorchis </em>and <em>Opisthorchis</em> eggs is difficult; both are oval in shape and measure approximately 20 to 30 microns by 15 microns  (<a class="graphic graphic_picture graphicRef65990" href="/z/d/graphic/65990.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef52742" href="/z/d/graphic/52742.html" rel="external">picture 2</a>). Species differentiation is usually based upon geographic exposure and/or adult fluke morphology.</p><p></p><p class="bulletIndent1">In light infections, eggs may not be present or may be detectable only in concentrated specimens. Other causes of false negative results include intermittent egg excretion and biliary duct obstruction (preventing release of eggs into the stool).</p><p></p><p class="bulletIndent1">In the setting of suspected liver fluke infection but negative stool microscopy, serial stool samples should be examined; in addition, alternative diagnostic tools should be pursued if feasible. (See <a class="local">'Serologic, antigen, and molecular tests'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adult worm identification</strong> – Adult worms may be found at endoscopy or endoscopic retrograde cholangiopancreatography; they may also be passed in the stool following anthelminthic therapy [<a href="#rid8">8</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adult <em>C. sinensis</em> worms are flat and elongated, measuring 10 to 25 mm long and 3 to 5 mm wide  (<a class="graphic graphic_picture graphicRef76798" href="/z/d/graphic/76798.html" rel="external">picture 3</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adult <em>O. felineus</em> and <em>O. viverrini</em> worms are usually 8 to 12 mm long, but <em>O. felineus</em> tends to be wider (2 to 3 mm compared with 1 to 2 mm)  (<a class="graphic graphic_picture graphicRef64159" href="/z/d/graphic/64159.html" rel="external">picture 4</a>). </p><p></p><p class="headingAnchor" id="H2682767716"><span class="h4">Imaging</span><span class="headingEndMark"> — </span>Imaging tools for diagnosis of clonorchiasis or opisthorchiasis include ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ultrasonography</strong> – Ultrasound abnormalities may be observed in the setting of asymptomatic and symptomatic infection. In one study including 123 Korean patients with clonorchiasis, ultrasound abnormalities were observed in 49 percent of cases [<a href="#rid38">38</a>]. </p><p></p><p class="bulletIndent1">Ultrasound findings include gallbladder enlargement and/or sludge, bile duct dilatation, inflammation and/or fibrosis, and hepatomegaly [<a href="#rid39">39</a>]. Flukes within the gallbladder move in response to gentle palpation with the transducer over the gallbladder. Ultrasound may also detect aggregates of flukes as nonshadowing echogenic foci within bile ducts  (<a class="graphic graphic_diagnosticimage graphicRef57766" href="/z/d/graphic/57766.html" rel="external">image 1</a>) [<a href="#rid40">40</a>]. </p><p></p><p class="bulletIndent1">In one study of including 316 Korean patients with clonorchiasis, four sonographic findings distinguished patients with active disease from controls: (1) increased periductal echogenicity (sensitivity and specificity: 35 and 91 percent, respectively), (2) floating echogenic foci in the gallbladder (sensitivity and specificity: 28 and 94 percent, respectively), (3) diffuse intrahepatic bile duct dilatation (sensitivity and specificity: 67 and 48 percent, respectively), and (4) gallbladder distention (sensitivity and specificity: 3 and 100 percent, respectively) [<a href="#rid41">41</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CT and MRI</strong> – CT and MRI facilitate evaluation for dilation and thickening of the small intrahepatic bile ducts; they are also useful tools for detection of fibrosis, calcification, and hyperplasia [<a href="#rid42">42</a>]. </p><p></p><p class="headingAnchor" id="H3133749"><span class="h4">Serologic, antigen, and molecular tests</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serology</strong> – Serologic testing for opisthorchiasis and clonorchiasis using an enzyme-linked immunosorbent assay (ELISA) is performed in some laboratories but is not widely available [<a href="#rid43">43-45</a>]. The assay cannot reliably distinguish between current and past infection and may cross-react with other parasitic infections [<a href="#rid43">43</a>]. </p><p></p><p class="bulletIndent1">More sensitive and specific antigen-based detection assays, including monoclonal antibody-based enzyme-linked immunosorbent assay (mAb-ELISA) and immunoblot assays, have been developed using somatic and excretory-secretory (ES) antigens [<a href="#rid46">46,47</a>]. Sensitivity and specificity vary depending on the antigen used and the intensity of infection. </p><p></p><p class="bulletIndent1">Data suggest that mAb assays may able to detect light infection with only a few adult worms; in one study, immunoblot assays using <em>C. sinensis</em>-specific ES antigens demonstrated sensitivity and specificity of 76 and 95 percent, respectively [<a href="#rid48">48,49</a>]. </p><p></p><p class="bulletIndent1">A rapid diagnostic immunochromatographic kit for point-of-care diagnosis of opisthorchiasis and clonorchiasis using ES products from adult <em>O. viverrini</em> worms has demonstrated favorable sensitivity and specificity compared with ELISA (95 and 91 percent, respectively) [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen tests</strong> – Urine antigen detection is an emerging method for detection of opisthorchiasis and is a promising tool for diagnosis and mass screening [<a href="#rid50">50</a>]. In one study including more than 1000 people in Thailand, the prevalence of <em>O. viverrini</em> (determined by urine antigen detection) correlated well with stool antigen detection; both methods demonstrated 10 to 15 percent higher prevalence than stool microscopy [<a href="#rid51">51</a>]. Among patients with negative stool microscopy, urine and stool antigen were positive in 29 and 43 percent of cases, respectively. Another study showed higher sensitivity and negligible day-to-day variation of the urine antigen tests compared with fecal egg counts [<a href="#rid52">52</a>]. Antigen tests may decline or revert to negative approximately four weeks after treatment, suggesting that they may be helpful in differentiating current from past infection and for monitoring treatment outcomes [<a href="#rid53">53,54</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Molecular tests</strong> – Polymerase chain reaction (PCR)-based methods for detecting <em>O. viverrini</em>, <em>O. felineus</em>, and <em>C. sinensis</em> eggs in stool have been developed but are not commercially available [<a href="#rid55">55-57</a>]. Compared with standard stool microscopy, the sensitivity of PCR in specimens containing &gt;1000, 200 to 1000, and &lt;200 eggs per gram of stool, has been found to be 100 percent, 68 percent, and 50 percent, respectively. High specificity of tests is reported [<a href="#rid58">58</a>].</p><p></p><p class="headingAnchor" id="H1071556581"><span class="h2">Differential diagnosis</span></p><p class="bulletIndent1"><span class="glyph">●</span>Other fluke infections – These include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fascioliasis – Clinical manifestations of fascioliasis include fever, right upper quadrant pain, hepatomegaly, and occasional jaundice. Fascioliasis may be distinguished from infection due to other liver flukes by the presence of hypodense lesions on CT imaging as well as by stool microscopy and serology. (See  <a class="medical medical_review" href="/z/d/html/5676.html" rel="external">"Liver flukes: Fascioliasis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Schistosomiasis – Clinical manifestations of chronic schistosomiasis include signs of portal hypertension, abnormal liver function tests, and eosinophilia. The diagnosis is established by serology and/or microscopy. (See  <a class="medical medical_review" href="/z/d/html/5717.html" rel="external">"Schistosomiasis: Epidemiology and clinical manifestations"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Strongyloidiasis – Clinical manifestations of strongyloidiasis include abdominal pain, diarrhea, anorexia, nausea, vomiting, and eosinophilia; strongyloidiasis may present with eosinophilia in the absence of other symptoms. The diagnosis is established by serology and/or microscopy. (See  <a class="medical medical_review" href="/z/d/html/5714.html" rel="external">"Strongyloidiasis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ascariasis – Ectopic ascariasis can be a cause of extrahepatic biliary obstruction, with clinical manifestations of abdominal pain and jaundice. The diagnosis is established by serology, microscopy, and/or visualization via endoscopic retrograde cholangiopancreatography. (See  <a class="medical medical_review" href="/z/d/html/5673.html" rel="external">"Ascariasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute viral hepatitis – Clinical manifestations of acute viral hepatitis include fever, right upper quadrant pain, and fatigue, in the absence of eosinophilia. The diagnosis of acute viral hepatitis is established via serology. (See  <a class="medical medical_review" href="/z/d/html/2692.html" rel="external">"Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Choledocholithiasis – Clinical manifestations of choledocholithiasis include right upper quadrant pain and liver function tests consistent with cholestasis (elevated bilirubin and alkaline phosphatase). The diagnosis is established via ultrasonography. (See  <a class="medical medical_review" href="/z/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cholangiocarcinoma – Clinical manifestations of cholangiocarcinoma include jaundice, pruritus, clay-colored stools, dark urine, abdominal pain, weight loss, and fever. Liver function tests demonstrate a cholestatic picture. Diagnostic tools include magnetic resonance cholangiopancreatography and tumor markers. (See  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Primary sclerosing cholangitis – Clinical manifestations of primary sclerosing cholangitis may include fatigue, pruritus, jaundice, hepatomegaly, and splenomegaly. Liver function tests demonstrate a cholestatic picture. The diagnosis is established via cholangiography. (See  <a class="medical medical_review" href="/z/d/html/660.html" rel="external">"Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>Treatment is warranted for patients with positive stool microscopy, in the presence or absence of symptoms [<a href="#rid40">40</a>]. Treatment is also warranted for patients with a presumptive diagnosis of clonorchiasis or opisthorchiasis (based on relevant epidemiologic exposure, presence of eosinophilia, and ultrasonographic findings consistent with fluke infection), even in the setting of negative stool microscopy. </p><p>Goals of treatment include management of symptoms (if present), as well as minimizing the risk of chronic infection and associated complications, including cholangiocarcinoma. (See <a class="local">'Chronic infection and complications'</a> above.) </p><p class="headingAnchor" id="H288642675"><span class="h3">Clinical approach</span><span class="headingEndMark"> — </span>Treatment of clonorchiasis or opisthorchiasis consists of anthelminthic therapy. Additional intervention may be needed depending on the nature of the clinical presentation. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anthelminthic therapy</strong> – <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">Praziquantel</a> is the preferred agent. Eggs typically disappear from the stool within a week of treatment. However, clinical symptoms may take months to resolve, and biliary ductal abnormalities may persist after treatment [<a href="#rid59">59</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">Praziquantel</a> – The treatment of clonorchiasis or opisthorchiasis consists of praziquantel (25 mg/kg orally three times daily for one to two days) [<a href="#rid13">13,60</a>]. We agree with the World Health Organization guidance, which favors two days of treatment; however, some regional treatment guidelines consist of one day of treatment. Cure rates are high (&gt;90 percent) with either regimen but appear even higher with the two-day regimen (100 percent) [<a href="#rid61">61-65</a>]. A systematic review showed that the WHO-recommended praziquantel regimen (25 mg/kg three times a day for 2 days) had a high cure rate (98.5%; 85.4-99.9) in <em>C. sinensis</em> infection, and in <em>O. viverrini</em> infection, regimens of 75 mg/kg or 50 mg/kg of praziquantel given in a single day showed predicted cure rates of 93.8 percent (85.7-97.5) and 92.1 percent (64.9-98.6), respectively [<a href="#rid66">66</a>]. </p><p></p><p class="bulletIndent1">Adverse effects of <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> include headache, dizziness, insomnia, nausea, and vomiting.</p><p></p><p class="bulletIndent2">Administration of <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> for two days is supported by two trials including 100 patients with clonorchiasis [<a href="#rid60">60,61</a>] as well as one trial including 25 patients with opisthorchiasis [<a href="#rid62">62</a>] in which cure rates of 100 percent were achieved (based on stool microscopy and clinical symptoms) [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent2">Administration of <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> for one day is supported by a trial including 37 patients with clonorchiasis or opisthorchiasis randomly assigned to treatment with praziquantel (25 mg/kg/dose orally three times daily for one day) or placebo; the cure rate (based on stool microscopy) with this regimen was &gt;90 percent [<a href="#rid64">64</a>]. </p><p></p><p class="bulletIndent2">For treatment of light infection due to opisthorchiasis (&lt;1000 eggs per gram of stool by Kato-Katz technique), single-dose <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> (30 to 50 mg/kg) was similarly effective as the standard regimen with lower rates of adverse effects; additional study for moderate and heavy infection is needed [<a href="#rid65">65,67</a>]. </p><p></p><p class="bulletIndent2">A lower dose <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> regimen is less effective. In one study including 21 Vietnamese patients with clonorchiasis treated with praziquantel (25 mg/kg once daily for three days), the cure rate was only 29 percent [<a href="#rid68">68</a>]. Similarly, in a trial including 12 patients with opisthorchiasis treated with the same regimen, the cure rate was 44 percent [<a href="#rid65">65</a>].    </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Alternative agents</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">Albendazole</a> – Albendazole (10 mg/kg orally with fatty meal for seven days) is a potential alternative agent. In one study including 200 children with hookworm infection (of whom 55 were coinfected with <em>O. viverrini</em>, the cure rate (based on stool microscopy) for single-dose albendazole was 33 percent [<a href="#rid69">69</a>]. In one case series of 86 patients with clonorchiasis who were tested after treatment with a four-day course of albendazole, the cure rate was 91 percent [<a href="#rid70">70</a>]. A systematic review of albendazole 400mg bd for 5 or 7 days resulted in cure rates of 100 percent [<a href="#rid66">66</a>], although studies were of limited size.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Tribendimidine – Tribendimidine may be at least as efficacious as <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> for treatment of opisthorchiasis [<a href="#rid71">71-74</a>]. In a randomized trial including more than 600 patients with <em>O. viverrini</em> infection treated with tribendimidine (single oral dose; 200 mg for children, 400 mg for adolescents and adults) or praziquantel (two doses; 50 mg/kg followed by 25 mg/kg, six hours apart), the cure rates (negative stool microscopy at three weeks follow-up) were 94 and 97 percent, respectively [<a href="#rid73">73</a>]. Adverse events were mild but were more frequent in the praziquantel group. A systematic review showed that a single dose of 400 mg tribendimidine had a predicted cure rate of 89.8 percent (77.5-95.8) [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional interventions</strong> – Biliary decompression (endoscopic, percutaneous, or surgical) may be warranted in some circumstances; indications may include biliary duct stones and/or cholangitis. </p><p></p><p class="bulletIndent1">In such cases, bile should be sent to evaluate for eggs and adult worms. </p><p></p><p class="bulletIndent1">Issues related to management of complications (such as biliary obstruction, stone formation, cholangitis, cholecystitis, liver abscess, pancreatitis, hepatitis, and cirrhosis) are discussed separately (see related topics). </p><p></p><p class="headingAnchor" id="H1118875909"><span class="h3">Follow-up</span><span class="headingEndMark"> — </span>The optimal approach to monitoring for cholangiocarcinoma is uncertain; baseline ultrasonography abnormalities often persist following anthelminthic treatment. One study which followed individuals with <em>O. viverrini</em> infections and advanced periportal fibrosis (APF) for up to five years after <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> therapy found that about one third of patients (31 percent) had no relapse in APF, whereas 38 percent showed persistence or relapse of ultrasonic hepatobiliary abnormalities [<a href="#rid75">75</a>]. We favor annual ultrasonography following treatment of infection [<a href="#rid76">76</a>]. </p><p>Further evaluation of the efficacy of follow-up screening is needed [<a href="#rid77">77</a>]. In one study including 347 Korean patients who underwent ultrasonography one year after completing treatment for clonorchiasis, most patients had persistent findings of periductal echogenicity and intrahepatic bile duct dilatation; floating echogenic foci in the gallbladder improved in about one third of cases [<a href="#rid78">78</a>]. In another study including 104 patients in Thailand with opisthorchiasis and advanced periductal fibrosis who underwent annual ultrasonography for five years after anthelminthic treatment, persistent or relapsed fibrosis was observed in 37 percent of cases; 5 cases of cholangiocarcinoma were observed [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Prevention</span><span class="headingEndMark"> — </span>Prevention tools include: </p><p class="bulletIndent1"><span class="glyph">●</span>Education to reduce consumption of raw or undercooked fish – Transmission can be prevented by cooking; alternatively, fish may be frozen to internal temperature of -4°F for at least seven days [<a href="#rid79">79</a>]. Preparation methods that are not reliable to reduce transmission include salting, drying, pickling, and smoking [<a href="#rid48">48</a>]. Health literacy programs have also showed benefits [<a href="#rid80">80</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Improved hygiene to prevent water contamination. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mass drug administration − In regions where opisthorchiasis is endemic, mass treatment with <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> (40 mg/kg single dose) has been used, with cure rates (based on stool examination) ranging from 88 to 100 percent [<a href="#rid53">53,65,81</a>].</p><p></p><p>Some control programs in endemic areas have resulted in reduced prevalence; however, complete elimination may not be possible, particularly if domestic cat and dog reservoir hosts serve as a persistent reservoir of infection [<a href="#rid48">48</a>].</p><p>Vaccines are an area of ongoing study [<a href="#rid82">82</a>].</p><p class="headingAnchor" id="H17"><span class="h1">METORCHIS SPECIES</span><span class="headingEndMark"> — </span><em>M. conjunctus</em> is a liver fluke endemic to North America [<a href="#rid83">83</a>]. Most cases occur among native Canadian populations; stool surveys in these communities have demonstrated occasional asymptomatic human infection [<a href="#rid84">84,85</a>]. <em>Metorchis belis</em> occurs in Russia and Central and Eastern Europe; the geographic distribution overlaps with <em>O. felineus</em> [<a href="#rid83">83</a>]. <em>Metorchis orientalis </em>has been reported in Eastern Asia, specifically in China [<a href="#rid86">86</a>]<em>. </em> </p><p><em>Metorchis</em> spp are in the same family (Opisthorchiidae) as <em>C. sinensis</em>, <em>O. viverrini</em>, and <em>O. felineus</em>; all of these organisms have the same life cycle  (<a class="graphic graphic_figure graphicRef53219" href="/z/d/graphic/53219.html" rel="external">figure 2</a>) and seem to cause indistinguishable clinical symptoms, although data are limited due to the paucity of confirmed cases [<a href="#rid5">5</a>]. The different species cannot be distinguished morphologically or via light microscopy of eggs [<a href="#rid83">83</a>]; molecular methods are required for differentiation but are not available for routine use in clinical practice. Many fish-eating mammals (including dogs, fox, seals, and others) serve as definitive hosts. Aquatic snails serve as the first intermediate host; aquatic fish including the white sucker (<em>Catostomus commersoni</em>) serve as the second intermediate hosts. Humans are incidental hosts.</p><p>One outbreak of <em>M. conjunctus</em> among 19 Canadian patients was attributed to sushi prepared with raw white sucker fish [<a href="#rid87">87</a>]. Clinical manifestations (fever, anorexia, epigastric pain, and weight loss) and/or laboratory abnormalities (elevated serum transaminase concentration in 10 patients; eosinophilia in 15 patients) developed 1 to 15 days following ingestion of the raw fish. Stool microscopy demonstrated eggs among 10 patients; the eggs were indistinguishable from <em>O. viverrini</em>. Symptoms persisted for 3 to 28 days but responded promptly to treatment with <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> in all cases. It is uncertain whether prolonged infection or biliary complications can occur with <em>M. conjunctus</em>.</p><p class="headingAnchor" id="H2424689"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clonorchiasis and opisthorchiasis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epidemiology</strong> – Clonorchiasis and opisthorchiasis are liver fluke infections are acquired via ingestion of raw, undercooked, salted, dried, pickled, or smoked freshwater fish from endemic areas. Cats, dogs, and other fish-eating mammals serve as reservoir hosts  (<a class="graphic graphic_figure graphicRef53219" href="/z/d/graphic/53219.html" rel="external">figure 2</a>) (see <a class="local">'Epidemiology'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Clonorchiasis is caused by<em> Clonorchis</em> <em>sinensis</em>; it is endemic in China, Japan, Korea, Taiwan, and Vietnam. </p><p></p><p class="bulletIndent3">Opisthorchiasis is caused by <em>Opisthorchis felineus</em> or <em>Opisthorchis viverrini</em>.<em> O. felineus</em> occurs in Southeast Asia and in Central and Eastern Europe; <em>O. viverrini</em> is endemic in Thailand, Vietnam, Cambodia, Laos, China, and Myanmar. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical manifestations </strong>(see <a class="local">'Clinical manifestations'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Acute infection – Most acutely infected individuals are asymptomatic. Symptomatic infection is most common among older adults in endemic areas (given risk for ongoing exposure and increased worm burden with age); onset of symptoms may be delayed for many years following initial infection. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Chronic infection and complications – Late manifestations may include biliary obstruction (as well as strictures and/or dilatation), stone formation, cholangitis, cholecystitis, liver abscess, pancreatitis, hepatitis, and cirrhosis. In addition, such patients are at risk for cholangiocarcinoma, particularly in the setting of heavy infection. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis</strong> (see <a class="local">'Diagnosis'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The diagnosis of clonorchiasis or opisthorchiasis should be suspected in individuals with relevant epidemiologic exposure (consumption of raw or undercooked fish from endemic areas) and typical clinical manifestations (fatigue, abdominal discomfort, jaundice, anorexia, weight loss, dyspepsia), with or without eosinophilia. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The diagnosis may be established by identifying eggs in stool, which generally become detectable three to four weeks after exposure  (<a class="graphic graphic_picture graphicRef65990" href="/z/d/graphic/65990.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef52742" href="/z/d/graphic/52742.html" rel="external">picture 2</a>). In addition, ultrasonography should be pursued to evaluate the biliary tract and assess for findings warranting acute intervention (such as presence of biliary duct stones, cholangitis, cholecystitis, or abscess). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment </strong>– For treatment of clonorchiasis or opisthorchiasis in both symptomatic and asymptomatic individuals, we suggest treatment with <a class="drug drug_general" data-topicid="9805" href="/z/d/drug information/9805.html" rel="external">praziquantel</a> (25 mg/kg/dose orally three times daily for two days) rather than other treatment regimens (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent2">Additional intervention for management of complications may be needed depending on the nature of the clinical presentation. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Follow up</strong> − The optimal approach to monitoring for cholangiocarcinoma is uncertain; baseline ultrasonography abnormalities often persist following anthelminthic treatment. We favor annual ultrasonography following treatment of infection. (See <a class="local">'Follow-up'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metorchis infection</strong> – <em>Metorchis species</em> can cause liver fluke disease in humans. The life cycles, morphology, and microscopy are comparable with those seen in clonorchiasis or opisthorchiasis. In confirmed cases, acute clinical manifestations include fever, anorexia, epigastric pain, and weight loss; eosinophilia is common. It is unknown whether prolonged infection or biliary complications can occur. Diagnosis consists of stool microscopy; treatment as for clonorchiasis or opisthorchiasis. (See <a class="local">'Metorchis species'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev 2009; 22:466.</a></li><li><a class="nounderline abstract_t">Lai DH, Hong XK, Su BX, et al. Current status of Clonorchis sinensis and clonorchiasis in China. Trans R Soc Trop Med Hyg 2016; 110:21.</a></li><li><a class="nounderline abstract_t">Rim HJ. Clonorchiasis: an update. J Helminthol 2005; 79:269.</a></li><li><a class="nounderline abstract_t">Wang KX, Zhang RB, Cui YB, et al. Clinical and epidemiological features of patients with clonorchiasis. World J Gastroenterol 2004; 10:446.</a></li><li><a class="nounderline abstract_t">Chai JY, Jung BK. Epidemiology of Trematode Infections: An Update. Adv Exp Med Biol 2019; 1154:359.</a></li><li><a class="nounderline abstract_t">Qian MB, Utzinger J, Keiser J, Zhou XN. Clonorchiasis. Lancet 2016; 387:800.</a></li><li><a class="nounderline abstract_t">Keiser J, Utzinger J. Emerging foodborne trematodiasis. Emerg Infect Dis 2005; 11:1507.</a></li><li class="breakAll">Mahanty S, Maclean JD, Cross JH. Liver, Lung, and Intestinal Fluke Infections. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.854.</li><li><a class="nounderline abstract_t">Kim BJ, Ock MS, Kim IS, Yeo UB. Infection status of Clonorchis sinensis in residents of Hamyang-gun, Gyeongsangnam-do, Korea. Korean J Parasitol 2002; 40:191.</a></li><li><a class="nounderline abstract_t">Li Z, Xin H, Qian MB, et al. Clonorchis sinensis Reinfection Rate and Reinfection Determinants: A Prospective Cohort Study in Hengxian County, Guangxi, China. J Infect Dis 2022; 225:481.</a></li><li><a class="nounderline abstract_t">Fedorova OS, Fedotova MM, Zvonareva OI, et al. Opisthorchis felineus infection, risks, and morbidity in rural Western Siberia, Russian Federation. PLoS Negl Trop Dis 2020; 14:e0008421.</a></li><li><a class="nounderline abstract_t">Pakharukova MY, Mordvinov VA. The liver fluke Opisthorchis felineus: biology, epidemiology and carcinogenic potential. Trans R Soc Trop Med Hyg 2016; 110:28.</a></li><li><a class="nounderline abstract_t">Control of foodborne trematode infections. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1995; 849:1.</a></li><li><a class="nounderline abstract_t">Aung WPP, Htoon TT, Tin HH, et al. First report and molecular identification of Opisthorchis viverrini infection in human communities from Lower Myanmar. PLoS One 2017; 12:e0177130.</a></li><li><a class="nounderline abstract_t">Andrews RH, Sithithaworn P, Petney TN. Opisthorchis viverrini: an underestimated parasite in world health. Trends Parasitol 2008; 24:497.</a></li><li><a class="nounderline abstract_t">Yossepowitch O, Gotesman T, Assous M, et al. Opisthorchiasis from imported raw fish. Emerg Infect Dis 2004; 10:2122.</a></li><li><a class="nounderline abstract_t">Morsy AT, Al-Mathal EM. Clonorchis sinensis a new report in Egyptian employees returning back from Saudi Arabia. J Egypt Soc Parasitol 2011; 41:221.</a></li><li><a class="nounderline abstract_t">Lewin MR, Weinert MF. An eighty-four-year-old man with fever and painless jaundice: a case report and brief review of Clonorchis sinensis infection. J Travel Med 1999; 6:207.</a></li><li><a class="nounderline abstract_t">Upatham ES, Viyanant V, Kurathong S, et al. Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in north-east Thailand. Bull World Health Organ 1984; 62:451.</a></li><li><a class="nounderline abstract_t">Pungpak S, Harinasuta T, Bunnag D, et al. Fecal egg output in relation to worm burden and clinical features in human opisthorchiasis. Southeast Asian J Trop Med Public Health 1990; 21:275.</a></li><li><a class="nounderline abstract_t">Qian MB, Li HM, Jiang ZH, et al. Severe hepatobiliary morbidity is associated with Clonorchis sinensis infection: The evidence from a cross-sectional community study. PLoS Negl Trop Dis 2021; 15:e0009116.</a></li><li><a class="nounderline abstract_t">Marcos LA, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 2008; 21:523.</a></li><li><a class="nounderline abstract_t">Traverso A, Repetto E, Magnani S, et al. A large outbreak of Opisthorchis felineus in Italy suggests that opisthorchiasis develops as a febrile eosinophilic syndrome with cholestasis rather than a hepatitis-like syndrome. Eur J Clin Microbiol Infect Dis 2012; 31:1089.</a></li><li><a class="nounderline abstract_t">Fürst T, Duthaler U, Sripa B, et al. Trematode infections: liver and lung flukes. Infect Dis Clin North Am 2012; 26:399.</a></li><li><a class="nounderline abstract_t">Pungpak S, Chalermrut K, Harinasuta T, et al. Opisthorchis viverrini infection in Thailand: symptoms and signs of infection--a population-based study. Trans R Soc Trop Med Hyg 1994; 88:561.</a></li><li><a class="nounderline abstract_t">Stauffer WM, Sellman JS, Walker PF. Biliary liver flukes (Opisthorchiasis and Clonorchiasis) in immigrants in the United States: often subtle and diagnosed years after arrival. J Travel Med 2004; 11:157.</a></li><li><a class="nounderline abstract_t">Chan HH, Lai KH, Lo GH, et al. The clinical and cholangiographic picture of hepatic clonorchiasis. J Clin Gastroenterol 2002; 34:183.</a></li><li><a class="nounderline abstract_t">Sripa B, Jumnainsong A, Tangkawattana S, Haswell MR. Immune Response to Opisthorchis viverrini Infection and Its Role in Pathology. Adv Parasitol 2018; 102:73.</a></li><li><a class="nounderline abstract_t">Chaiyadet S, Sotillo J, Smout M, et al. Carcinogenic Liver Fluke Secretes Extracellular Vesicles That Promote Cholangiocytes to Adopt a Tumorigenic Phenotype. J Infect Dis 2015; 212:1636.</a></li><li><a class="nounderline abstract_t">Thinkhamrop K, Khuntikeo N, Laohasiriwong W, et al. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. PLoS Negl Trop Dis 2021; 15:e0009741.</a></li><li><a class="nounderline abstract_t">Ghidini M, Ramai D, Facciorusso A, et al. Metabolic disorders and the risk of cholangiocarcinoma. Expert Rev Gastroenterol Hepatol 2021; 15:999.</a></li><li><a class="nounderline abstract_t">Sripa B, Deenonpoe R, Brindley PJ. Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma? Parasitol Int 2017; 66:383.</a></li><li><a class="nounderline abstract_t">Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:210.</a></li><li><a class="nounderline abstract_t">Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002; 89:962.</a></li><li><a class="nounderline abstract_t">Chen W, Ning D, Wang X, et al. Identification and characterization of Clonorchis sinensis cathepsin B proteases in the pathogenesis of clonorchiasis. Parasit Vectors 2015; 8:647.</a></li><li><a class="nounderline abstract_t">Sripa B, Tangkawattana S, Brindley PJ. Update on Pathogenesis of Opisthorchiasis and Cholangiocarcinoma. Adv Parasitol 2018; 102:97.</a></li><li><a class="nounderline abstract_t">Surapaitoon A, Suttiprapa S, Mairiang E, et al. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma. Korean J Parasitol 2017; 55:295.</a></li><li><a class="nounderline abstract_t">Hong ST, Yoon K, Lee M, et al. Control of clonorchiasis by repeated praziquantel treatment and low diagnostic efficacy of sonography. Korean J Parasitol 1998; 36:249.</a></li><li><a class="nounderline abstract_t">Elkins DB, Mairiang E, Sithithaworn P, et al. Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans. Am J Trop Med Hyg 1996; 55:295.</a></li><li><a class="nounderline abstract_t">Liu LX, Harinasuta KT. Liver and intestinal flukes. Gastroenterol Clin North Am 1996; 25:627.</a></li><li><a class="nounderline abstract_t">Choi D, Hong ST, Lim JH, et al. Sonographic findings of active Clonorchis sinensis infection. J Clin Ultrasound 2004; 32:17.</a></li><li><a class="nounderline abstract_t">Lim JH. Radiologic findings of clonorchiasis. AJR Am J Roentgenol 1990; 155:1001.</a></li><li><a class="nounderline abstract_t">Sakolvaree Y, Ybanez L, Chaicumpa W. Parasites elicited cross-reacting antibodies to Opisthorchis viverrini. Asian Pac J Allergy Immunol 1997; 15:115.</a></li><li><a class="nounderline abstract_t">Wongsaroj T, Sakolvaree Y, Chaicumpa W, et al. Affinity purified oval antigen for diagnosis of Opisthorchiasis viverrini. Asian Pac J Allergy Immunol 2001; 19:245.</a></li><li><a class="nounderline abstract_t">Lin YL, Chen ER, Yen CM. Antibodies in serum of patients with clonorchiasis before and after treatment. Southeast Asian J Trop Med Public Health 1995; 26:114.</a></li><li><a class="nounderline abstract_t">Watwiengkam N, Sithithaworn J, Duenngai K, et al. Improved performance and quantitative detection of copro-antigens by a monoclonal antibody based ELISA to diagnose human opisthorchiasis. Acta Trop 2013; 128:659.</a></li><li><a class="nounderline abstract_t">Sadaow L, Sanpool O, Rodpai R, et al. Development of an Immunochromatographic Point-of-Care Test for Serodiagnosis of Opisthorchiasis and Clonorchiasis. Am J Trop Med Hyg 2019; 101:1156.</a></li><li><a class="nounderline abstract_t">Saijuntha W, Sithithaworn P, Kiatsopit N, et al. Liver Flukes: Clonorchis and Opisthorchis. Adv Exp Med Biol 2019; 1154:139.</a></li><li><a class="nounderline abstract_t">Li S, Shin JG, Cho PY, et al. Multiple recombinant antigens of Clonorchis sinensis for serodiagnosis of human clonorchiasis. Parasitol Res 2011; 108:1295.</a></li><li><a class="nounderline abstract_t">Worasith C, Kamamia C, Yakovleva A, et al. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. PLoS Negl Trop Dis 2015; 9:e0004157.</a></li><li><a class="nounderline abstract_t">Worasith C, Wangboon C, Duenngai K, et al. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. PLoS Negl Trop Dis 2019; 13:e0007186.</a></li><li><a class="nounderline abstract_t">Worasith C, Wongphutorn P, Homwong C, et al. Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in Northeast Thailand. PLoS One 2022; 17:e0271553.</a></li><li><a class="nounderline abstract_t">Worasith C, Wangboon C, Kopolrat KY, et al. Application of urine antigen assay to evaluate outcomes of praziquantel treatment and reinfection in opisthorchiasis in northeast Thailand. Trans R Soc Trop Med Hyg 2020; 114:751.</a></li><li><a class="nounderline abstract_t">Thinkhamrop K, Khuntikeo N, Sithithaworn P, et al. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand. Infect Dis Poverty 2019; 8:18.</a></li><li><a class="nounderline abstract_t">Lamaningao P, Kanda S, Laimanivong S, et al. Development of a PCR Assay for Diagnosing Trematode (Opisthorchis and Haplorchis) Infections in Human Stools. Am J Trop Med Hyg 2017; 96:221.</a></li><li><a class="nounderline abstract_t">Kim EM, Verweij JJ, Jalili A, et al. Detection of Clonorchis sinensis in stool samples using real-time PCR. Ann Trop Med Parasitol 2009; 103:513.</a></li><li><a class="nounderline abstract_t">Duflot M, Setbon T, Midelet G, et al. A review of molecular identification tools for the opisthorchioidea. J Microbiol Methods 2021; 187:106258.</a></li><li><a class="nounderline abstract_t">Saijuntha W, Sithithaworn P, Petney TN, Andrews RH. Foodborne zoonotic parasites of the family Opisthorchiidae. Res Vet Sci 2021; 135:404.</a></li><li><a class="nounderline abstract_t">Leung JW, Sung JY, Banez VP, et al. Endoscopic cholangiopancreatography in hepatic clonorchiasis--a follow-up study. Gastrointest Endosc 1990; 36:360.</a></li><li><a class="nounderline abstract_t">Chen CY, Hsieh WC. Clonorchis sinensis: epidemiology in Taiwan and clinical experience with praziquantel. Arzneimittelforschung 1984; 34:1160.</a></li><li><a class="nounderline abstract_t">Soh CT. Clonorchis sinensis: experimental and clinical studies with praziquantel in Korea. Arzneimittelforschung 1984; 34:1156.</a></li><li><a class="nounderline abstract_t">Bunnag D, Harinasuta T. Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel. Southeast Asian J Trop Med Public Health 1980; 11:528.</a></li><li><a class="nounderline abstract_t">Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 2010; 73:197.</a></li><li><a class="nounderline abstract_t">Jong EC, Wasserheit JN, Johnson RJ, et al. Praziquantel for the treatment of Clonorchis/Opisthorchis infections: report of a double-blind, placebo-controlled trial. J Infect Dis 1985; 152:637.</a></li><li><a class="nounderline abstract_t">Bunnag D, Harinasuta T. Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel. Southeast Asian J Trop Med Public Health 1981; 12:413.</a></li><li><a class="nounderline abstract_t">Qian MB, Patel C, Palmeirim MS, et al. Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis. Lancet Microbe 2022; 3:e616.</a></li><li><a class="nounderline abstract_t">Sayasone S, Meister I, Andrews JR, et al. Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial. Clin Infect Dis 2017; 64:451.</a></li><li><a class="nounderline abstract_t">Tinga N, De N, Vien HV, et al. Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study. Trop Med Int Health 1999; 4:814.</a></li><li><a class="nounderline abstract_t">Soukhathammavong PA, Sayasone S, Phongluxa K, et al. Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis 2012; 6:e1417.</a></li><li><a class="nounderline abstract_t">Ying-Yan Z, Ting-Jun X, Man W, et al. [Prevalence of Clonorchis sinensis infection and effect of albendazole treatment among residents in two communities of Zhongshan City]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2018; 30:219.</a></li><li><a class="nounderline abstract_t">Soukhathammavong P, Odermatt P, Sayasone S, et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis 2011; 11:110.</a></li><li><a class="nounderline abstract_t">Qian MB, Yap P, Yang YC, et al. Efficacy and safety of tribendimidine against Clonorchis sinensis. Clin Infect Dis 2013; 56:e76.</a></li><li><a class="nounderline abstract_t">Sayasone S, Keiser J, Meister I, et al. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. Lancet Infect Dis 2018; 18:155.</a></li><li><a class="nounderline abstract_t">Meister I, Assawasuwannakit P, Vanobberghen F, et al. Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of Opisthorchis viverrini Infections. Antimicrob Agents Chemother 2019; 63.</a></li><li><a class="nounderline abstract_t">Mairiang E, Laha T, Kaewkes S, et al. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study. Acta Trop 2021; 217:105853.</a></li><li><a class="nounderline abstract_t">Khuntikeo N, Koonmee S, Sa-Ngiamwibool P, et al. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. HPB (Oxford) 2020; 22:874.</a></li><li><a class="nounderline abstract_t">Khuntikeo N, Chamadol N, Yongvanit P, et al. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 2015; 15:459.</a></li><li><a class="nounderline abstract_t">Choi D, Jeon YH, Lee GC, et al. Changes in sonographic findings after treatment of patients with clonorchiasis in a heavy endemic area. Korean J Parasitol 2009; 47:19.</a></li><li><a class="nounderline abstract_t">Huang Y, Huang D, Geng Y, et al. An Integrated Control Strategy Takes Clonorchis sinensis Under Control in an Endemic Area in South China. Vector Borne Zoonotic Dis 2017; 17:791.</a></li><li><a class="nounderline abstract_t">Moonsan S, Songserm N, Woradet S, Suksatan W. Effects of Health Literacy Promotion Programs for Preventing Opisthorchiasis and Cholangiocarcinoma: a Systematic Review and Meta-analysis. J Cancer Educ 2023; 38:1322.</a></li><li><a class="nounderline abstract_t">Vivatanasesth P, Sornmani S, Schelp FP, et al. Mass treatment of opisthorchiasis in Northeast Thailand. Southeast Asian J Trop Med Public Health 1982; 13:609.</a></li><li><a class="nounderline abstract_t">Zhang J, Sun Y, Zheng J. Prospects for liver fluke vaccines. Exp Parasitol 2021; 230:108170.</a></li><li><a class="nounderline abstract_t">Mordvinov VA, Yurlova NI, Ogorodova LM, Katokhin AV. Opisthorchis felineus and Metorchis bilis are the main agents of liver fluke infection of humans in Russia. Parasitol Int 2012; 61:25.</a></li><li><a class="nounderline abstract_t">Brassard P, Hoey J, Ismail J, Gosselin F. The prevalence of intestinal parasites and enteropathogenic bacteria in James Bay Cree Indians, Quebec. Can J Public Health 1985; 76:322.</a></li><li><a class="nounderline abstract_t">Behr MA, Gyorkos TW, Kokoskin E, et al. North American liver fluke (Metorchis conjunctus) in a Canadian aboriginal population: a submerging human pathogen? Can J Public Health 1998; 89:258.</a></li><li><a class="nounderline abstract_t">Lin J, Chen Y, Li Y. The discovery of natural infection of human with Metorchis orientalis and the investigation of its focus. China J Zonoses 2001; 17:38.</a></li><li><a class="nounderline abstract_t">MacLean JD, Arthur JR, Ward BJ, et al. Common-source outbreak of acute infection due to the North American liver fluke Metorchis conjunctus. Lancet 1996; 347:154.</a></li></ol></div><div id="topicVersionRevision">Topic 5674 Version 34.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597009" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Food-borne trematodiases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26740359" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Current status of Clonorchis sinensis and clonorchiasis in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16153321" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clonorchiasis: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14760777" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical and epidemiological features of patients with clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31297768" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of Trematode Infections: An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26299184" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16318688" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Emerging foodborne trematodiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16318688" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Emerging foodborne trematodiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12509104" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Infection status of Clonorchis sinensis in residents of Hamyang-gun, Gyeongsangnam-do, Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34375427" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clonorchis sinensis Reinfection Rate and Reinfection Determinants: A Prospective Cohort Study in Hengxian County, Guangxi, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32598389" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Opisthorchis felineus infection, risks, and morbidity in rural Western Siberia, Russian Federation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26740360" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The liver fluke Opisthorchis felineus: biology, epidemiology and carcinogenic potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7740791" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Control of foodborne trematode infections. Report of a WHO Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28472153" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : First report and molecular identification of Opisthorchis viverrini infection in human communities from Lower Myanmar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18930439" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Opisthorchis viverrini: an underestimated parasite in world health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15663848" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Opisthorchiasis from imported raw fish.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21634255" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Clonorchis sinensis a new report in Egyptian employees returning back from Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10467158" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : An eighty-four-year-old man with fever and painless jaundice: a case report and brief review of Clonorchis sinensis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6331907" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in north-east Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2237595" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Fecal egg output in relation to worm burden and clinical features in human opisthorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33507969" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Severe hepatobiliary morbidity is associated with Clonorchis sinensis infection: The evidence from a cross-sectional community study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18725803" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21938537" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A large outbreak of Opisthorchis felineus in Italy suggests that opisthorchiasis develops as a febrile eosinophilic syndrome with cholestasis rather than a hepatitis-like syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22632646" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Trematode infections: liver and lung flukes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7992340" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Opisthorchis viverrini infection in Thailand: symptoms and signs of infection--a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15710057" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Biliary liver flukes (Opisthorchiasis and Clonorchiasis) in immigrants in the United States: often subtle and diagnosed years after arrival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11782616" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The clinical and cholangiographic picture of hepatic clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30442311" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Immune Response to Opisthorchis viverrini Infection and Its Role in Pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25985904" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Carcinogenic Liver Fluke Secretes Extracellular Vesicles That Promote Cholangiocytes to Adopt a Tumorigenic Phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34543283" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34423721" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Metabolic disorders and the risk of cholangiocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27919744" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22108757" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Global burden of human food-borne trematodiasis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12153620" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Liver fluke-associated cholangiocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26691339" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Identification and characterization of Clonorchis sinensis cathepsin B proteases in the pathogenesis of clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30442312" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Update on Pathogenesis of Opisthorchiasis and Cholangiocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28719954" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9868890" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Control of clonorchiasis by repeated praziquantel treatment and low diagnostic efficacy of sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8842118" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8863043" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Liver and intestinal flukes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14705173" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Sonographic findings of active Clonorchis sinensis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2120925" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Radiologic findings of clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9346276" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Parasites elicited cross-reacting antibodies to Opisthorchis viverrini.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12009074" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Affinity purified oval antigen for diagnosis of Opisthorchiasis viverrini.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8525396" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Antibodies in serum of patients with clonorchiasis before and after treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24055716" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Improved performance and quantitative detection of copro-antigens by a monoclonal antibody based ELISA to diagnose human opisthorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31482789" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Development of an Immunochromatographic Point-of-Care Test for Serodiagnosis of Opisthorchiasis and Clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31297762" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Liver Flukes: Clonorchis and Opisthorchis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21125293" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Multiple recombinant antigens of Clonorchis sinensis for serodiagnosis of human clonorchiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26485024" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30735492" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35853022" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in Northeast Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32735672" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Application of urine antigen assay to evaluate outcomes of praziquantel treatment and reinfection in opisthorchiasis in northeast Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30890188" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27821695" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Development of a PCR Assay for Diagnosing Trematode (Opisthorchis and Haplorchis) Infections in Human Stools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19695156" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Detection of Clonorchis sinensis in stool samples using real-time PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34082051" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A review of molecular identification tools for the opisthorchioidea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33158552" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Foodborne zoonotic parasites of the family Opisthorchiidae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2210276" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Endoscopic cholangiopancreatography in hepatic clonorchiasis--a follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6391504" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Clonorchis sinensis: epidemiology in Taiwan and clinical experience with praziquantel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6391503" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Clonorchis sinensis: experimental and clinical studies with praziquantel in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7013095" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20627144" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The drugs we have and the drugs we need against major helminth infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3897401" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Praziquantel for the treatment of Clonorchis/Opisthorchis infections: report of a double-blind, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7342331" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35697047" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28174906" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10632989" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22235353" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29770671" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : [Prevalence of Clonorchis sinensis infection and effect of albendazole treatment among residents in two communities of Zhongshan City].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21111681" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23223597" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Efficacy and safety of tribendimidine against Clonorchis sinensis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29153938" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30718244" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of Opisthorchis viverrini Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33548204" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31662222" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26054405" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Cohort profile: cholangiocarcinoma screening and care program (CASCAP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19290087" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Changes in sonographic findings after treatment of patients with clonorchiasis in a heavy endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29040056" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : An Integrated Control Strategy Takes Clonorchis sinensis Under Control in an Endemic Area in South China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36637714" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Effects of Health Literacy Promotion Programs for Preventing Opisthorchiasis and Cholangiocarcinoma: a Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7170644" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Mass treatment of opisthorchiasis in Northeast Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34699916" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Prospects for liver fluke vaccines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21840415" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Opisthorchis felineus and Metorchis bilis are the main agents of liver fluke infection of humans in Russia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3910211" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The prevalence of intestinal parasites and enteropathogenic bacteria in James Bay Cree Indians, Quebec.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9735521" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : North American liver fluke (Metorchis conjunctus) in a Canadian aboriginal population: a submerging human pathogen?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The discovery of natural infection of human with Metorchis orientalis and the investigation of its focus</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8544550" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Common-source outbreak of acute infection due to the North American liver fluke Metorchis conjunctus.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
